AAV Purification: Solving Downstream Challenges

Panelists:

Chantelle Gaskin
Field Applications Specialist
Thermo Fisher Scientific

Ganesh Krishnamoorthy, PhD
Director Downstream Process Development
Forge Biologics

Stephen Soltys
VP Process Development
Kriya Therapeutics

Broadcast Date:  June 16, 2023
Time: 8:00 am PT, 11:00 am ET, 17:00 CET

The rapid growth of gene therapy programs across a host of different diseases has been made possible in large part by our increased understanding of the efficiency and safety profiles of a deno – associated virus(AAV) vectors. To maximize the chances of success, AAV purification is a critical step in developing such programs, requiring researchers to solve a number of key downstream challenges.

In this timely roundtable discussion, a trio of distinguished experts in AAV purification and process development will share their expertise and best practices in tackling and solving downstream AAV purification challenges. Among the themes to be discussed will be industry trends, platform ability and the relentless need for innovation. Our guest panelists are: 

· Ganesh Krishnamoorthy, PhD – Director Downstream Process Development, Forge Biologics

· Stephen Soltys – VP Process Development, Kriya Therapeutics

· Chantelle Gaskin – Field ApplicationScientist, Thermo Fisher Scientific

A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelists.

Produced with support from:

The post AAV Purification: Solving Downstream Challenges appeared first on GEN – Genetic Engineering and Biotechnology News.

therapeutics
gene therapy
biologics